Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"thrombolytics"”.
-
Developing Novel Platelet-Based Targeting Strategies for Thrombolytics
Use of plasminogen activators (PAs) as thrombolytic drugs is restricted to life threatening thrombotic settings because these therapies are associated with a high risk of bleeding. We hypothesize that platelet-delivered PAs would preferentially lyse nascent, pathological clots that are actively …
-
Barriers To Timely Administration Of Thrombolytics In Acute Ischemic Stroke Patients
… States. The therapeutic benefits of intravenous thrombolytics is time dependent in an acute ischemic stroke patient and is an important determinant of 90 day and one year functional outcomes. This study investigated areas in the stroke alert process of a community based primary stroke care center …
-
A mathematical model for magnetically-assisted delivery of thrombolytics in occluded blood vessels for ischemic stroke treatment
… treatment is intravenous administration of thrombolytics like alteplase. Once administered, the rate of thrombolytic delivery to a clot in a fully occluded vessel is limited by the slow process of diffusion. This is problematic as increased duration of the hypoxic state due to a thrombus or …
-
Cost-effectiveness of improving access to treatments for acute ischemic stroke in Peru
… of symptom onset, 4) and appropriate use of thrombolytics. Scenario 1 looked at certifying hospitals to become basic stroke care centers that could provide thrombolytics to persons currently seeking care. Scenario 2 built on scenario 1 by adding an evidence-based mass media campaign to …
-
The Application of Transcranial High Intensity Focused Ultrasound to Clot Lysis
… acute ischemic stroke - the administration of thrombolytics - is associated with a relatively low efficacy and a large number of patients are contraindicated against the use of the drug. This research was motivated by the need to develop a new treatment modality for acute ischemic stroke that …
-
Thrombolysis of Blood Clots using Wirelessly Powered Inferior Vena Cava Filters
… the positive attributes of anticoagulants and thrombolytics without the associated adverse effects. Computer simulations and in vitro experiments were conducted to assess the feasibility and effectiveness of a wirelessly powered filter. The filters are designed to capture and then heat blood …
-
A Minimally Invasive Ultrasound Therapy Based On Time- Reversal Acoustics For The Treatment Of Deep Vein Thrombosis
… methodology that would reduce the dosage of thrombolytics and anti -coagulants without reducing the efficacy of treating the thrombus.
-
Risk assessment of patients as a means of directing a clinical pharmacy service
… regular prescriptions, anti-epileptics, thrombolytics/anticoagulants, central nervous system agents, and chemotherapy / immunosuppressants. The area under the ROC for the risk score was 0.61. Multiple factors were significantly and independently associated, with an increased intervention …
-
Critical path management for acute myocardial infarction
… mortality, length of hospital stay, and use of thrombolytics. The primary endpoints were changes in usage of ASA and betablocker after the critical path protocol. The increase in use of ASA was 1.89% (p=0.511) and in the use of beta-blocker was 4.85% (p=0.381). Secondary endpoints of in-hospital …
-
Novel Strategies for the Prevention of Post-Stroke Epilepsy and Sudden Unexpected Death in Epilepsy Patients
… Although currently available therapies such as thrombolytics and mechanical thrombectomy prevent immediate mortality by restoring blood flow after stroke, these treatments do not target the cellular and molecular mechanisms that lead to post-stroke epileptogenesis. With the increasing number of …
-
Improving Outreach with Stroke Patients after Discharge
… the outreach in stroke patients treated with thrombolytics alone or in combination with mechanical endovascular reperfusion (MER) therapy. An audit of calls was completed and revealed a gap that a number of patients were not reached or did not receive a call attempt. Having a higher outreach …
-
The Protective Role of Transglutaminase 2 in Ischemic Stroke
… in the US. Currently, administration of thrombolytics is the only approved therapy. Due to the variability, small management time window, and lack of options for effective treatment, there is a clear need for new compounds to alleviate cell death post-stroke. Transglutaminase 2 (TG2) can …
-
Time to Medical Help-Seeking for Adults Who Experience Symptoms of Stroke in a California-Mexico Border Region
… late for first-line treatment with intravenous thrombolytics. It is necessary to identify those at risk for delayed medical help-seeking in order to decrease stroke mortality and long-term disabilities.
-
The Association Between Group Identity and Advanced Therapies in a Cohort of Patients Hospitalized with Venous Thromboembolic Disease: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study.
… therapies, defined as the use of systemic thrombolytics, CDT, surgical thrombectomy, catheter-guided thrombectomy, or ECMO. Our primary analysis evaluated the association between group identity and use of advanced therapies using multivariable logistic regression to estimate adjusted odds …
-
Glial Growth Factor 2 as a treatment in a monkey model of cortical injury
… cause of death and disability worldwide. While thrombolytics can be used to restore blood flow immediately following the onset of symptoms of an ischemic stroke, there are currently no neurorestorative therapeutics that can enhance long-term recovery of function following injury. Neuregulins are …